Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | EQNR | MCK |
|---|---|---|
| Price | $43.22 | $877.59 |
| Change today | ▲ 0.75% | ▼ 0.33% |
| Market cap | $102.46B | $102.32B |
| Return, 3 months | +38.1% | +14.6% |
| Return, year to date | +89.1% | +7.3% |
| Return, 1 year | +76.6% | +15.8% |
| P/E (TTM) | 11.7 | 23.4 |
| P/B | 2.4 | -24.1 |
| P/E percentile vs own 5y | 79th | 38th |
| Dividend yield | 3.47% | 0.37% |
| Revenue growth (YoY, latest qtr) | +37.4% | +7.7% |
| Net profit growth (YoY) | +267.2% | +24.2% |
| Gross margin | 40.4% | 3.6% |
| Operating margin | 28.0% | 1.7% |
| Net margin | 8.0% | 1.1% |
| Return on equity | 21.3% | – |
| Analyst target vs. price | -14.4% | +14.0% |
| Analyst buy share | 0% | 83% |
| RSI (14) | 51 | 56 |
| 30-day volatility | 32.7% | 27.1% |
| Max drawdown, 1 year | -26.1% | -27.2% |
| Trend read | Leaning bullish | Leaning bullish |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.